Quest Diagnostics (DGX) FCF Payout Ratio: 2009-2025
Historic FCF Payout Ratio for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to 0.21.
- Quest Diagnostics' FCF Payout Ratio fell 36.78% to 0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year decrease of 22.07%. This contributed to the annual value of 0.36 for FY2024, which is 0.20% up from last year.
- According to the latest figures from Q3 2025, Quest Diagnostics' FCF Payout Ratio is 0.21, which was up 2.90% from 0.21 recorded in Q2 2025.
- Over the past 5 years, Quest Diagnostics' FCF Payout Ratio peaked at 1.58 during Q1 2024, and registered a low of -2.24 during Q1 2023.
- Its 3-year average for FCF Payout Ratio is 0.21, with a median of 0.25 in 2024.
- Within the past 5 years, the most significant YoY rise in Quest Diagnostics' FCF Payout Ratio was 286.12% (2023), while the steepest drop was 1,363.64% (2023).
- Quest Diagnostics' FCF Payout Ratio (Quarterly) stood at 0.23 in 2021, then soared by 75.53% to 0.40 in 2022, then crashed by 56.16% to 0.18 in 2023, then surged by 40.10% to 0.25 in 2024, then tumbled by 36.78% to 0.21 in 2025.
- Its FCF Payout Ratio stands at 0.21 for Q3 2025, versus 0.21 for Q2 2025 and 0.43 for Q1 2025.